Abstract
Extracorporeal membrane oxygenation (ECMO) is a form of cardiopulmonary bypass, modified such that patients can be supported for a prolonged period of time, even weeks. ECMO is not a treatment, but rather supports the patient until their lung and/or cardiac function improves. ECMO was developed for use in adult patients, but abandoned when initial trials failed to demonstrate that it improved survival advantage over that achieved by conventional respiratory support [1]. Subsequently, Bartlett and colleagues demonstrated the potential of ECMO for neonates with severe respiratory failure. Now, many thousands of neonates have been recorded on the Extracorporeal Life Support Organisation (ELSO) database as having received ECMO. In this chapter, the techniques used and the management of a neonate on ECMO are described. In addition, the indications for ECMO and the results achieved are discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReference
Zapol WM, Snider MT, Hill JD et al (1979) Extracorporeal membrane oxygenation in severe respiratory failure. JAMA 242: 2193–2196
UK Collaborative ECMO Trial Group (1996) UK collaborative randomized trial of neonatal extracorporeal membrane oxygenation. Lancet 248: 75–82
Mugford M, Elbourne D, Field D (2008) Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database Syst Rev 3:CD001340
Frenckner B, Radell P (2008) Respiratory failure and extracorporeal membrane oxygenation. Semin Pediatr Surg 17: 34–45
Bennett CC, Johnson A, Filed DJ and the UK Collaborative ECMO Group (2001) UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years. Lancet 357: 1094–1096
McNally H, Bennett CC, Elbourne D, UK Collaborative ECMO Group (2006) United Kingdom Collaborative Randomised Trial of Neonatal Extracorporeal Membrane Oxygenation: follow-up to age 7 years. Pediatrics 117: e845–e854
Beardsmore C, Dundas I, Poole K et al (2000) Respiratory function in survivors of the United Kingdom Extracorporeal Membrane Oxygenation Trial. Am J Respir Crit Care Med 161: 1129–1135
Petrou S, Bischof M, Bennett C et al (2006) Cost effectiveness of neonatal extracorporeal membrane oxygenation based on 7 year results from the United Kingdom collaborative ECMO trial. Pediatrics 117: 1640–1649
Hitz SR, Suttner DM, Sheehan AM (2000) Decreased use of extracorporeal membrane oxygenation (ECMO): how new treatments have affected ECMO utilisation. Pediatrics 106: 1339–1343
Coppola CP, Tyree M, Larry K, DiGeronimo R (2008) A 22 year experience in global transport extracorporeal membrane oxygenation. J Pediatr Surg 43: 46–52
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Greenough, A., Agha, M., Smith, A.P.R. (2012). Extracorporeal Membrane Oxygenation for Neonates. In: Buonocore, G., Bracci, R., Weindling, M. (eds) Neonatology. Springer, Milano. https://doi.org/10.1007/978-88-470-1405-3_72
Download citation
DOI: https://doi.org/10.1007/978-88-470-1405-3_72
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1404-6
Online ISBN: 978-88-470-1405-3
eBook Packages: MedicineMedicine (R0)